Geron Announces New Overall Survival Data from IMbark in Imetelstat-Treated Patients Pharmaceutical Investing
Momenta Pharmaceuticals Provides Update on US Regulatory Strategy for M923, Proposed Biosimilar to HUMIRA Life Science Investing
Agios Presents Updated Data from the Ivosidenib Phase 1 Dose-Escalation and Expansion Trial Life Science Investing
Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Study Pharmaceutical Investing
Zogenix Announces Positive Phase 3 Trial Results on the Efficacy and Safety of FINTEPLA (ZX008) in Dravet Syndrome Life Science Investing
Principia Biopharma Reports Positive PRN1008 Phase 2 Top-Line Results and Initiates Phase 3 Pemphigus Program Pharmaceutical Investing
Harvest One Pleased To Announce Record Revenues For First Quarter Of Fiscal 2019 Cannabis Investing News
